BIOMAT Database Logo BIOMAT Database Logo

Unusual complications in a patient receiving streptokinase treatment for deep venous thrombosis. 1981

J McGregor, and A C Roach

UI MeSH Term Description Entries
D008297 Male Males
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

J McGregor, and A C Roach
Streptokinase for deep venous thrombosis.
January 1984, Henry Ford Hospital medical journal,
J McGregor, and A C Roach
Streptokinase and deep venous thrombosis.
May 1981, Lancet (London, England),
J McGregor, and A C Roach
Streptokinase treatment for deep vein thrombosis.
October 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J McGregor, and A C Roach
[Streptokinase in the treatment of deep venous thrombosis and pulmonary embolism].
January 1978, Annales de l'anesthesiologie francaise,
J McGregor, and A C Roach
[Streptokinase treatment of deep thrombosis].
November 1971, Nordisk medicin,
J McGregor, and A C Roach
[Deep venous thrombosis: streptokinase treatment with adaptation of the maintenance dosage].
August 1980, Medizinische Klinik,
J McGregor, and A C Roach
Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis.
August 1978, Klinische Wochenschrift,
J McGregor, and A C Roach
[Results of streptokinase-plasminogen therapy in deep venous thrombosis].
April 1983, Die Medizinische Welt,
J McGregor, and A C Roach
[Effectiveness of streptokinase preparations in experimental deep venous thrombosis].
December 1973, Problemy gematologii i perelivaniia krovi,
J McGregor, and A C Roach
[Treatment of venous thrombosis with streptokinase].
July 1974, Lakartidningen,
Copied contents to your clipboard!